Telmisartan A Plus Tablets 80/5/12.5 mg (Telmisartan, Amlodipine Besilate, Chlorthalidone)

Adult dose

This medication is to be taken once daily, one tablet, with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., morning) if possible. For patients whose blood pressure is not controlled with telmisartan/amlodipine combination therapy, this medication 40/5/12.5 mg may be prescribed, and the dosage should be adjusted after at least a 2-week interval based on the patient's blood pressure response. The maximum dose of this medication is 80/5/25.

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can pose serious risks to the fetus. Potential problems may include decreased renal function in the fetus, cranial formation disorders, renal failure, etc., so if pregnancy is confirmed, the medication should be discontinued immediately. Patients with impaired liver function or progressing liver disease should be cautious, as serious side effects such as hepatic coma may occur. Patients with severely impaired kidney function should avoid its use as some ingredients may accumulate in the body and lead to toxicity. Patients who have had allergic reactions to any component of this medication or similar drugs, as well as pregnant or breastfeeding women, and those with severe liver impairment or renal failure, should not take this medication. Patients with heart valve disease, cardiomyopathy, gastrointestinal disease, elderly patients, and others with specific conditions should use this medication with increased caution and follow a physician's instructions. This medication has a blood pressure-lowering effect, so dizziness or hypotension may appear during early administration; if symptoms are severe, consult a healthcare professional immediately. There is a risk of elevated potassium levels; therefore, caution is needed when taking potassium supplements or potassium-containing foods together. Patients with decreased renal function should regularly undergo blood tests to monitor kidney function and electrolyte levels. This medication may interact with other antihypertensives, certain diuretics, anti-inflammatory medications, etc., so inform your doctor of any other medications you are taking. Dizziness or drowsiness may occur while driving or operating dangerous machinery; caution is advised. In case of overdose, symptoms such as hypotension, dizziness, and cardiac function decline may appear, and immediate treatment should be sought at a hospital. Keep out of reach of children and store in a cool, dry place away from direct sunlight.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory difficulties accompanied by cough and fever, yellowing of the skin or eyes (jaundice), overall extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, difficult urination

Mild side effects

• Dizziness
• dyslipidemia
• back pain
• rash
• headache
• abdominal pain
• rectal bleeding
• nausea
• hemorrhagic gastritis
• constipation

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Furthermore, it is best to keep the medication at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer time.

Appearance

White oval-shaped bilayer tablet

Package unit

30 tablets/box [(10 tablets/PTP*3)], 30 tablets/bottle